List view / Grid view
6 October 2014 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center announced a novel clinical research collaboration to evaluate multiple immunotherapies...
6 October 2014 | By The Ministry of Health
The Ministry of Health has installed a Biosafety Level 3 (BSL-3) mobile lab outside East Arafat Hospital as part of its public-health preparedness program for Hajj...
6 October 2014 | By CleveXel Pharma
They will address the treatment of bone marrow cancers and the diagnosis of patients who are resistant to standard treatments...
3 October 2014 | By OBN
OBN revealed last night the winners of its Annual Awards celebrating the best of UK life sciences – the innovators, fundraisers and dealmakers who underline the pre-eminence of the UK sector in the global marketplace...
3 October 2014 | By Allied-Bristol Life Sciences
Allied-Bristol Life Sciences today announced that Satish Jindal, Ph.D., formerly Vice President of R&D within Bristol-Myers, has been appointed to lead the company’s efforts to identify and foster development of biopharmaceutical innovations from top U.S. university research institutions...
3 October 2014 | By Agar Scientific
Paul joins Agar Scientific from Ronexprim SRL – where he was an Executive Director and the Area Sales Manager for PANalytical X-ray equipment and FEI electronic microscopes in Romanian territories...
2 October 2014 | By Eli Lilly and Company
Eli Lilly and Company announced today it will discontinue development of tabalumab -- being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) -- due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns. ..
News from the European Pharmacopoeia:
2 October 2014 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company will announce results for the third quarter on Friday, October 24, 2014...
Scientists involved in materials characterization, process validation and product failure analysis can gather more valuable data by combining two powerful analytical techniques. The new Thermo Scientific TGA-IR Module provides users of Thermo Scientific FT-IR spectrometers with enhanced performance when combining Thermal Gravimetric Analysis (TGA) and FT-IR spectroscopy.
1 October 2014 | By Daiichi Sankyo
Daiichi Sankyo Company Limited announced that it and its domestic generic subsidiary, Daiichi Sankyo Espha Co., Ltd. have submitted a supplemental New Drug Application (sNDA) in Japan...
1 October 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announced that adult asthma patients could benefit from a new treatment...
1 October 2014 | By Cardio3 BioSciences
Cardio3 BioSciences announces that it has recently increased its business development activities, building on its core expertise in cellular therapies and in cardiovascular diseases...
1 October 2014 | By DKSH Business Unit Healthcare
DKSH, the leading Market Expansion Services provider with a focus on Asia, signed an agreement to provide commercial and distribution services to Novo Nordisk, a global healthcare company with 90 years of experience in diabetes care, in Malaysia...
30 September 2014 | By Celerion
Celerion, announces the expansion of ophthalmological services in our Belfast, Northern Ireland UK facility, by building on our successful relationship with Queen’s University in Belfast...
